| P2093 | author name string | Jimmy Lee | |
| | Milawaty Nurjono | |
| | Siow-Ann Chong | |
| P2860 | cites work | Altered levels of acute phase proteins in the plasma of patients with schizophrenia | Q48515944 |
| | Deficits in Small Interneurons in Prefrontal and Cingulate Cortices of Schizophrenic and Schizoaffective Patients | Q48633690 |
| | Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia | Q48694105 |
| | Hippocampal volume and the brain-derived neurotrophic factor Val66Met polymorphism in first episode psychosis. | Q48759855 |
| | Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia | Q48890957 |
| | Lack of effect of brain derived neurotrophic factor (BDNF) Val66Met polymorphism on early onset schizophrenia in Chinese Han population | Q48900083 |
| | Synaptic degeneration in thalamus in schizophrenia | Q48919076 |
| | Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth | Q24656080 |
| | Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects | Q28657600 |
| | The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function | Q29615582 |
| | Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies | Q31043017 |
| | Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism | Q31960799 |
| | Inflammation-related genes up-regulated in schizophrenia brains | Q33297810 |
| | BDNF is not associated with schizophrenia: data from a Japanese population study and meta-analysis | Q33437356 |
| | Circulating brain-derived neurotrophic factor and indices of metabolic and cardiovascular health: data from the Baltimore Longitudinal Study of Aging | Q33559688 |
| | An inverse relationship between cortisol and BDNF levels in schizophrenia: data from human postmortem and animal studies. | Q33572408 |
| | Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. | Q33814201 |
| | HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment | Q33824172 |
| | Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume | Q33849008 |
| | Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? | Q33886050 |
| | Inflammation in psychotic disorders: a population-based study. | Q50792655 |
| | Differences in distribution of ages of onset in males and females with schizophrenia. | Q50860568 |
| | Gender and schizophrenia: association of age at onset with antecedent, clinical and outcome features. | Q50875287 |
| | Decreased T cellular immune response in schizophrenic patients. | Q51282803 |
| | The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. | Q51478010 |
| | Association of serum BDNF levels with hippocampal volumes in first psychotic episode drug-naive schizophrenic patients. | Q51581475 |
| | Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics. | Q51929862 |
| | Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology. | Q51953367 |
| | Schizophrenia | Q55868331 |
| | Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: A positive correlation | Q58950504 |
| | Treatment with estrogen and progesterone affects relative levels of brain-derived neurotrophic factor mRNA and protein in different regions of the adult rat brain | Q73118945 |
| | Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients | Q73407505 |
| | Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration | Q73911873 |
| | A review of longitudinal studies of cognitive functions in schizophrenia patients | Q77154319 |
| | T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatment | Q80192507 |
| | Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment | Q80383450 |
| | Is prediction of cardiovascular disease and all-cause mortality genuinely driven by the metabolic syndrome, and independently from its component variables? The Dubbo study | Q83481122 |
| | Functional variants of the genes involved in neurodevelopment and susceptibility to schizophrenia in an Armenian population | Q84276310 |
| | Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics | Q34019168 |
| | Schizophrenia as a disorder of neurodevelopment | Q34132313 |
| | Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis | Q34132832 |
| | Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease? | Q34286983 |
| | Local and target-derived actions of neurotrophins during peripheral nervous system development. | Q34350911 |
| | Neurotrophins and neuronal differentiation in the central nervous system. | Q34350923 |
| | The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia | Q34410132 |
| | Review of immunological and immunopathological findings in schizophrenia | Q34487620 |
| | The impact of childhood abuse and recent stress on serum brain-derived neurotrophic factor and the moderating role of BDNF Val66Met | Q34608856 |
| | BDNF regulates eating behavior and locomotor activity in mice | Q34667950 |
| | Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology | Q34783101 |
| | Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders | Q34828363 |
| | Cell biology of BDNF and its relevance to schizophrenia | Q34987347 |
| | Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases | Q35071710 |
| | Schizophrenia: from phenomenology to neurobiology | Q35146132 |
| | Estrogen-BDNF interactions: implications for neurodegenerative diseases. | Q35690176 |
| | Twenty-five year mortality of a community cohort with schizophrenia | Q36028183 |
| | The neurodevelopmental model of schizophrenia: update 2005. | Q36034203 |
| | Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists. | Q36037466 |
| | Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia? | Q36404577 |
| | Brain-derived neurotrophic factor (BDNF) and food intake regulation: a minireview. | Q36457025 |
| | Increases in two truncated TrkB isoforms in the prefrontal cortex of people with schizophrenia | Q36471519 |
| | BDNF: a key regulator for protein synthesis-dependent LTP and long-term memory? | Q36663584 |
| | The changing scene of neurotrophic factors | Q36669560 |
| | Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene | Q36700576 |
| | Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine | Q36756397 |
| | Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities | Q36784651 |
| | Reduced hippocampal volumes in healthy carriers of brain-derived neurotrophic factor Val66Met polymorphism: meta-analysis | Q36798667 |
| | Inflammation and schizophrenia | Q36870045 |
| | Interaction between BDNF and serotonin: role in mood disorders | Q36946551 |
| | Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review | Q37001984 |
| | Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity | Q37031211 |
| | Regulation of neurogenesis by neurotrophins: implications in hippocampus-dependent memory | Q37218980 |
| | Schizophrenia, "just the facts": what we know in 2008 Part 3: neurobiology | Q37272278 |
| | Metabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular events: the Strong Heart Study. | Q37311398 |
| | The metabolic syndrome and schizophrenia | Q37365657 |
| | Schizophrenia, "just the facts" 4. Clinical features and conceptualization | Q37425853 |
| | Cytokines and schizophrenia: Microglia hypothesis of schizophrenia. | Q37541981 |
| | BDNF function and intracellular signaling in neurons. | Q37657342 |
| | Brain-derived neurotrophic factor: findings in schizophrenia | Q37830293 |
| | Estrogens and gonadal function in schizophrenia and related psychoses | Q37885256 |
| | The metabotrophic NGF and BDNF: an emerging concept | Q37894011 |
| | Effects of BDNF polymorphisms on brain function and behavior in health and disease. | Q37933605 |
| | Brain-derived neurotrophic factor, food intake regulation, and obesity | Q37938323 |
| | The role of BDNF in the pathophysiology and treatment of schizophrenia | Q37949790 |
| | Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand? | Q37968946 |
| | Brain Derived Neurotrophic Factor: a novel neurotrophin involved in psychiatric and neurological disorders | Q37979058 |
| | Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons | Q40115894 |
| | Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study | Q40545893 |
| | Purification of a new neurotrophic factor from mammalian brain | Q41303996 |
| | Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications | Q41525870 |
| | Mouse and rat BDNF gene structure and expression revisited | Q42772346 |
| | Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? | Q42943930 |
| | BDNF Val66Met polymorphism is associated with aggressive behavior in schizophrenia | Q43079583 |
| | Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort | Q43135141 |
| | Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophrenia | Q43147297 |
| | Size, shape, and orientation of neurons in the left and right hippocampus: investigation of normal asymmetries and alterations in schizophrenia | Q43875000 |
| | Estrogen regulates the development of brain-derived neurotrophic factor mRNA and protein in the rat hippocampus. | Q43940187 |
| | Mortality in schizophrenia | Q44143939 |
| | Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration | Q44189362 |
| | Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study | Q44344393 |
| | Brain-derived neurotrophic factor gene and schizophrenia: polymorphism screening and association analysis | Q44929466 |
| | Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients | Q45207542 |
| | Effects of brain-derived neurotrophic factor (BDNF) on glial cells and serotonergic neurones during development | Q45230312 |
| | Association of BDNF serum concentrations with central serotonergic activity: evidence from auditory signal processing | Q45236949 |
| | Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease | Q45283615 |
| | Decreased serum brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia | Q46050686 |
| | Chronic stress, as well as acute stress, reduces BDNF mRNA expression in the rat hippocampus but less robustly | Q46604356 |
| | BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia | Q46911651 |
| | Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics | Q47314314 |
| | Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions | Q47354472 |
| | Postnatal repeated maternal deprivation produces age-dependent changes of brain-derived neurotrophic factor expression in selected rat brain regions. | Q47900177 |
| | Local infusion of brain-derived neurotrophic factor modifies the firing pattern of dorsal raphé serotonergic neurons. | Q47917609 |
| | Cellular sources of enhanced brain-derived neurotrophic factor production in a mouse model of allergic inflammation | Q48102622 |
| | Meta-analysis of case-control association studies between the C270T polymorphism of the brain-derived neurotrophic factor gene and schizophrenia | Q48106481 |
| | Low serum truncated-BDNF isoform correlates with higher cognitive impairment in schizophrenia | Q48128316 |
| | Blood BDNF concentrations reflect brain-tissue BDNF levels across species | Q48138873 |
| | The C270T polymorphism of the brain-derived neurotrophic factor gene is associated with schizophrenia | Q48142556 |
| | Brain-derived neurotrophic factor gene polymorphisms and schizophrenia: a meta-analysis | Q48214700 |
| | Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis | Q48278687 |
| | Transport of brain-derived neurotrophic factor across the blood-brain barrier | Q48307102 |
| | Brain-derived neurotrophic factor controls dopamine D3 receptor expression: implications for neurodevelopmental psychiatric disorders | Q48328237 |
| | Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes | Q48447557 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P921 | main subject | biomarker | Q864574 |
| | schizophrenia | Q41112 |
| P304 | page(s) | 61-70 | |
| P577 | publication date | 2012-08-31 | |
| P1433 | published in | Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology | Q26842559 |
| P1476 | title | A Review of Brain-derived Neurotrophic Factor as a Candidate Biomarker in Schizophrenia | |
| P478 | volume | 10 | |